SEC Form 4 · accession 0001209191-17-052228
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer L Good
Director
Period of report
Sep 7, 2017
Accepted (ET)
Sep 11, 2017 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01F1 | Sep 7, 2017 | A | 15,000 | $0.00 | A | 15,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This restricted stock unit award shall vest ratably in three equal annual installments, with the first annual installment vesting on the one year anniversary of September 7, 2017 date.